Bausch Health Companies (TSE:BHC) Trading Down 1.7% - Here's Why

Key Points

• Bausch Health Companies Inc.'s stock price fell by 1.7%, trading between C$9.71 and C$9.89, with a total of 337,684 shares exchanged, a decrease from the average volume.
• The company's market capitalization stands at C$3.66 billion and it has a price-to-earnings ratio of 38.04.
• Bausch Health primarily develops and markets products in the therapeutic areas of eye health, gastroenterology, and dermatology.

Bausch Health Companies Inc. (TSE:BHC - )'s stock price dropped 1.7% during trading on Monday . The stock traded as low as C$9.71 and last traded at C$9.89. Approximately 337,684 shares were traded during trading, a decline of 10% from the average daily volume of 376,599 shares. The stock had previously closed at C$10.06.

Bausch Health Companies Trading Down 1.7%

The stock has a market capitalization of C$3.66 billion, a price-to-earnings ratio of 38.04, a PEG ratio of 0.21 and a beta of 0.48. The company's 50 day moving average is C$9.47 and its 200 day moving average is C$8.45. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.